It is a chemicals private limited company based in Huzur, Madhya Pradesh, India, established in 2021.
2021 | Huzur, Madhya Pradesh, India | ActiveNodilas Pharmaceuticals Private Limited, a active private limited company, was established on 03 November 2021 in Huzur, Madhya Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290MP2021PTC058269. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Seema Gupta (Director), Subhash Chandra Gupta (Director). Past directors included Deependra Singh, Deepak Tiwari, Satya Tiwari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O. Anant Lal Gupta, Amahiya Galla Mandi Rewa, Huzur, Madhya Pradesh, 486001.
U24290MP2021PTC058269
058269
03 November 2021
₹1.50 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Nodilas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seema Gupta | Director | 14 Sep 2024 | Current |
| Subhash Chandra Gupta | Director | 14 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Oct 2024 | Past |
| Pramod Abcsdd | Director | 26 Oct 2024 | Past |
| Pramod Abcsdd | Director | 26 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Nodilas Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Nodilas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Nodilas Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nodilas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nodilas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nodilas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Seema Gupta was appointed as a Director was appointed as a Director on 14 Sep 2024 & has been associated with this company since 1 year 3 months . was documented.
Subhash Chandra Gupta was appointed as a Director was appointed as a Director on 14 Sep 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Nodilas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
Progress on Nodilas Pharmaceuticals Private Limited was registered on 03 Nov 2021 with Roc Gwalior & aged 4 years 1 month as per MCA records. was documented.
The CIN of Nodilas Pharmaceuticals Private Limited is U24290MP2021PTC058269.
Nodilas Pharmaceuticals Private Limited is headquartered at C/O. Anant Lal Gupta, Amahiya Galla Mandi Rewa, Huzur, Madhya Pradesh, 486001.
Nodilas Pharmaceuticals Private Limited was incorporated on 03 November 2021.
The current directors of Nodilas Pharmaceuticals Private Limited are
The primary industry of Nodilas Pharmaceuticals Private Limited is Chemicals.
Nodilas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nodilas Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX